AIDS/HIV Therapy
Pharmacokinetic properties of reverse transcriptase inhibitors reviewed
Published in Medical Letter on the CDC and FDA, November 21st, 2004
"Options for antiretroviral therapy in patients infected with HIV continue to expand as new drugs are integrated into treatment regimens. Nonetheless, nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs) remain the backbone of highly active antiretroviral therapy (HAART). With the approval of emtricitabine in 2003, there are now eight Food and Drug Administration (FDA)-approved NRTIs/NtRTIs," researchers in the United States report.
"Several of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Botulism
Food-borne botulism in the United States reviewed - Enterovirus
Enterovirus 68 shares biological features with enteroviruses and rhinoviruses - Food Safety
Antimicrobial resistance risk assessment in food safety reviewed - Interleukins
Mechanism of action of IL-13 antagonist in cells expressing IL-4R determined - Trichomoniasis
Dicationic compounds effective against Trichomonas vaginalis identified - AIDS/HIV Vaccine
Kinetics of virus-specific CD8+ T cells in HIV infection determined - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
